CD44 isoform expression follows two alternative splicing pathways in breast tissue

American Journal of Pathology

Volumn 153, Issue 1, 1998, Pages 183-190

  Roca, Xavier ^a   Mate, José L ^a   Ariza, Aurelio ^a   Muñoz Mármol, Ana M ^b   Von Uexküll Güldeband, Claudia ^b   Pellicer, Inmaculada ^a   Navas Palacios, José J ^a   Isamat, Marcos ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Fundacion Echevarne   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; ISOPROTEIN; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; BREAST; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031816112     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65559-9     Document Type: Article

References (43)

1. Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991, 51:5054s-5059s
2. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336
3. Stamenkovic I, Amiot M, Pesando JM, Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989, 56:1057-1062
4. Screaton G, Bell M, Jackson D, Cornelis F, Gerth U: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992, 89:12160-12164
5. Breitbart RE, Andreadis A, Nadal-Ginard B: Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes. Annu Rev Biochem 1987, 56:467-495
6. Underhill CB: Hyaluronan is inversely correlated with the expression of CD44 in the dermal condensation of the embryonic hair follicle. J Invest Dermatol 1993, 101:820-826
7. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994, 124:71-82
8. Delfino DV, Patrene KD, DeLeo AB, DeLeo R, Herberman RB, Boggs SS: Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrow. J Immunol 1994, 152:5171-5179
9. Haegel H, Tölg C, Hofmann M, Cederig R: Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding. J Cell Biol 1993, 122:1067-1077
10. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zöller M: Participation in normal immune responses of a splice variant of CD44 that encodes a metastasis-inducing domain. Science 1992, 257:682-685
11. Screaton R, Càceres J, Mayeda A, Bell M, Plebanski M, Jackson D, Bell J, Krainer A: Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 1995, 14.17:4336-4349
12. Jackson DG, Screaton GR, Martyn VB, Dickinson R, Timans J, Shiels J, Whittle N, Collins I, Fawcett J, Simmons D, Bell JI: Structure of the CD44 gene and its expression during leucocyte activation. Fifth International Human Leukocyte Differentiation Antigen Workshop Handbook. Edited by Schlossman EF. Oxford, UK, Oxford University Press, 1995, pp 1727-1729
13. Càceres J, Stamm FS, Helfman DM, Krainer AR: Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 1994, 265:1706-1709
14. König H, Moll J, Ponta H, Herrlich P: Trans-acting factors regulate the expression of CD44 splice-variants. EMBO J 1996, 15:4030-4039
15. Herrlich P, Zöller M, Pals S, Ponta H: CD44 splice variants: metastases meet lymphocytes. Immunol Today 1993, 14.8:395-399
16. Lesley J, Hyman R, Kinkade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 1993, 54:271-335
17. Günthert U, Stauder R, Mayer B, Terpe H-J, Finke L, Friedrichs K: Are CD44 variant isoforms involved in human tumour progression? Cancer Surv 1995, 24:19-42
18. Ruiz P, Schwärzler C, Günthert, U: CD44 isoforms during differentiation and development. BioEssays 1995, 917:17-24
19. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 1990, 61:1303-1313
20. Stamenkovic I, Aruffo A, Amiot M, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991, 10:1057-1062
21. He Q, Lesley J, Hyman R, Ishihara K, Kincade PW: Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol 1992, 119:1711-1719
22. Peach JP, Hollenbaugh D, Stamenkovic I, Aruffo A: Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 1993, 122:257-264
23. Hamann KJ, Dowling TL, Neely SP, Grant JA, Leff AR: Hyaluronic acid enhances cell proliferation during eosinopoiesis through the CD44 surface antigen. J Immunol 1995, 154:4073-4080
24. Perschl A, Lesley J, English N, Trowbridge I, Hyman R: Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol 1995, 25:495-501
25. Takahashi K, Stamenkovic I, Cutler M, Dasgupta A, Tanabe KK: Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J Biol Chem 1996, 271:9490-9496
26. Dasgupta A, Takahashi K, Cutler M, Tanabe KK: O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells. Biochem Biophys Res Commun 1996, 227:110-117
27. Droll A, Dougherty ST, Chiu RK, Dirks JF, McBride WH, Cooper DL, Dougherty GJ: Adhesive interactions between alternatively spliced CD44 isoforms. J Biol Chem 1995, 270:11567-11573
28. Jackson D, Bell J, Dickinson R, Timans J, Shields J: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 1995, 128:673-685
29. Bennet KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A: CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995, 128:687-698
30. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haubmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991, 65:13-24
31. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993, 177:897-904
32. Heider K-H., Dämmrich J, Skroch-Angel P, Müller-Hermelink H-K, Vollmers HP, Herrlich P, Ponta H: Differential expression of CD44 splice variants in intestinal and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993, 53:4197-4203
33. Heider K-H, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P, Pals ST: A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993, 120:227-233
34. Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S: Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 1993, 122:431-442
35. Woodman AC, Sugiyama M, Yoshida K, Sugino T, Borgya A, Goodison S, Matsumumura Y, Tarin D: Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. Am J Pathol 1996, 149:1519-1530
36. Friedrichs K, Franke F, Lisboa B-W, Kügler G, Gille I, Terpe, H-J, Hölzel F, Maass H, Günthert, U: CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 1995, 55:5424-5433
37. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich, P: CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995, 345:615-619
38. Iida N, Bourguignon LYW: New CD44 splice variants associated with human breast cancers. J Cell Physiol 1995, 162:127-133
39. Joensuu H, Klemi PJ, Toikkanen S, Jalkanen S: Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 1993, 143:867-874
40. Screaton GR, Bell MV, Bell JI, Jackson DG: The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. J Biol Chem 1993, 268:12235-12238
41. Campbell JH, Campbell GR: The macrophage as an initiator of atherosclerosis. Clin Exp Pharmacol Physiol 1991, 18:81-84
42. Herman IM: Endothelial cell matrices modulate smooth muscle cell growth, contractile phenotype and sensitivity to heparin. Homeostasis 1990, 20:166-177
43. Rogalski TM, Williams BD, Mullen GP, Moerman DG: Products of the unc-52 gene in Caenorhabditis elegans are homologous to the core protein of the mammalian basement membrane heparan sulfate proteoglycan. Genes Dev 1993, 7:1471-1484